Non-Vitamin K Antagonist Oral Anticoagulants for the Treatment of Cerebral Venous Sinus Thrombosis: a Retrospective, Matched Cohort Analysis
ConclusionsThe safety and efficacy results of NOAC use for CVT were similar to those for age-matched and sex-matched controls treated with VKAs, as well as historical published controls. Assessment of NOAC efficacy and safety in CVT in multicenter cohort studies and randomized controlled trials is warranted.
Source: Neurocritical Care - Category: Neurology Source Type: research
More News: Bleeding | Brain | Cardiology | Disability | Heart | Hemorrhagic Stroke | History of Medicine | Neurology | Pradaxa | Stroke | Study | Thrombosis | Vitamin K | Vitamins | Washington University